Universität zu Köln

Riedel, Richard ORCID: 0000-0002-8883-1188, Ruge, Lea ORCID: 0000-0003-3390-0411, Verheyen, Malte ORCID: 0009-0008-7552-9044, John, Felix ORCID: 0000-0002-0616-3391, Scharpenseel, Heather ORCID: 0000-0001-6322-8350, Nogova, Lucia ORCID: 0000-0002-4502-1812, Michels, Sebastian ORCID: 0000-0003-3164-870X, Fischer, Rieke N. ORCID: 0009-0001-5271-2160, Eisert, Anna, Jakob, Carolin ORCID: 0009-0008-5641-6888, Niesen, Emanuel, Fassunke, Jana ORCID: 0000-0002-8391-5577, Siemanowski-Hrach, Janna ORCID: 0009-0000-8453-5229, Heydt, Carina ORCID: 0000-0003-3184-9579, Bunck, Anne, Siebolts, Udo ORCID: 0009-0000-2336-4737, Merkelbach-Bruse, Sabine ORCID: 0000-0002-0312-5760, Buettner, Reinhard ORCID: 0000-0001-8806-4786, Wolf, Jürgen ORCID: 0000-0002-3869-4736 and Scheffler, Matthias ORCID: 0000-0002-9031-1368 (2026). MET-Driven Resistance to Sotorasib in KRAS G12C–Mutant NSCLC and Response to Combined KRAS and MET Inhibition. JTO Clinical and Research Reports, 7 (3). pp. 1-7. Elsevier. ISSN 2666-3643

Michels, S. ORCID: 0000-0003-3164-870X, Massutí, B., Vasyliv, I., Stratmann, J., Frank, J., Adams, A. ORCID: 0000-0003-3286-1131, Felip, E., Grohé, C., Rodriguez-Abreu, D. ORCID: 0000-0003-0506-1366, Bischoff, H., Carcereny i Costa, E., Corral, J., Pereira, E., Fassunke, J. ORCID: 0000-0002-8391-5577, Fischer, R.N. ORCID: 0009-0001-5271-2160, Insa, A., Koleczko, S., Nogova, L. ORCID: 0000-0002-4502-1812, Reck, M. ORCID: 0000-0002-5348-4462, Reutter, T. ORCID: 0009-0001-5153-7049, Riedel, R. ORCID: 0000-0002-8883-1188, Schaufler, D., Scheffler, M. ORCID: 0000-0002-9031-1368, Weisthoff, M. ORCID: 0000-0001-6536-3898, Provencio, M., Merkelbach-Bruse, S. ORCID: 0000-0002-0312-5760, Hellmich, M. ORCID: 0000-0001-5174-928X, Sebastian, M. ORCID: 0000-0002-0404-7741, Büttner, R. ORCID: 0000-0001-8806-4786, Persigehl, T. ORCID: 0000-0001-5928-4405, Rosell, R. ORCID: 0000-0003-0817-3400 and Wolf, J. ORCID: 0000-0001-7577-464X (2024). Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial. ESMO Open, 9 (2). pp. 1-10. Elsevier. ISSN 2059-7029